Analyst Consensus ?
ConsensusHold62 ratings
Bullish2641.9%
Neutral3150.0%
Bearish58.1%
Check Point Software Technologies Ltd. · CHKP · FY2025 Q3 · Calendar Q4 2025
Check Point Q3: Billings Growth and Higher Revenue Outlook
The quarter’s 20% calculated-billings growth, revenue growth and raised revenue outlook support a constructive near-term operating picture. Whether that momentum is durable depends on recurring-revenue visibility, the hardware refresh cycle, and the company’s ability to manage foreign-exchange and acquisition-related margin pressure.
Reported Before market openNASDAQTechnology
$15.53B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$3.94
Consensus $2.45
EPS surprise
+60.8%
Reported versus consensus
Reported revenue
$677.5M
Consensus $673.2M
Revenue surprise
+0.6%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+6.2%
Event window
SPY move
+0.3%
Same window
Abnormal move
+5.9%
Stock minus SPY
Volume
3.4×
Versus trailing sessions
Subsequent drift
-8.7%
Up to 20 sessions
CHKPSPY benchmark
Ask FN2 about CHKP FY2025 Q3
Transcript, numbers and history already loaded
Why did CHKP rise 6.2% after beating EPS estimates in FY2025 Q3?What changed in CHKP's guidance and outlook in FY2025 Q3?Give me the bull and bear case for CHKP after FY2025 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, which described revenue guidance as maintained, the current quarter’s analysis reports that management raised the 2025 revenue-guidance midpoint by $15 million. Current analysis also emphasizes 20% calculated-billings growth and the completed Lakera acquisition.
Guidance delta
Management raised the midpoint of 2025 revenue guidance by $15 million. The supplied analysis notes modest FX and Lakera-related margin headwinds in Q4 and 2026.
Key takeaways
- Calculated billings grew 20% year over year; revenue increased 7% to $678 million.
- Management raised the 2025 revenue-guidance midpoint by $15 million.
- Operating cash flow was $241 million, up 23%; share repurchases totaled $325 million.
- The quarter’s positive growth signals coexist with anticipated FX and acquisition-related margin pressure.
Management priorities
- Integrate Lakera into an AI-security offering and expand AI-focused products.
- Scale SASE and hybrid-mesh offerings through product development and hiring.
- Build go-to-market capacity, including marketing and leadership hires.
- Explore consumption-based pricing for SASE and AI services.
Follow CHKP with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$141.5Current
$105Low
$155.21Average
$240High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 3, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Jefferies | Buy | Buy | Maintain | Oct 28, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Oct 26, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Oct 15, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Aug 3, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 3, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 31, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 31, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jul 31, 2026 |
| Stifel | Hold | Hold | Maintain | Jul 31, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 31, 2026 |
| JP Morgan | Neutral | Overweight | Downgrade | Jul 27, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 27, 2026 |
| Raymond James | Market Perform | Outperform | Downgrade | Jul 15, 2026 |
| Scotiabank | Sector Outperform | Sector Perform | Upgrade | Jul 6, 2026 |
| Guggenheim | Buy | Neutral | Upgrade | Jul 1, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | May 4, 2026 |
| Wedbush | Outperform | Outperform | Maintain | May 1, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | May 1, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | May 1, 2026 |
| Truist Securities | Buy | Buy | Maintain | Apr 24, 2026 |
| BWG Global | Negative | Mixed | Downgrade | Apr 14, 2026 |
| TD Cowen | Buy | Buy | Maintain | Feb 13, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Feb 13, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jan 5, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Sep 2, 2025 |
| Needham | Hold | Hold | Maintain | Feb 27, 2025 |
| Baird | Outperform | Neutral | Upgrade | Feb 27, 2025 |
| Deutsche Bank | Hold | Hold | Maintain | Jul 25, 2024 |
| William Blair | Outperform | Market Perform | Upgrade | Jan 31, 2024 |
| OTR Global | Mixed | Positive | Downgrade | Jul 10, 2023 |
| Credit Suisse | Underperform | Underperform | Maintain | May 2, 2023 |
| Wolfe Research | Outperform | Outperform | Maintain | Apr 17, 2023 |
| SMBC Nikko | Underperform | Neutral | Downgrade | Feb 16, 2023 |
| Macquarie | Neutral | Neutral | Maintain | Nov 2, 2022 |
| Summit Insights Group | Buy | Buy | Maintain | Apr 1, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Mar 10, 2022 |
| Oppenheimer | Perform | Outperform | Downgrade | Apr 9, 2021 |
| KeyBanc | Equal Weight | Sector Weight | Maintain | Nov 24, 2020 |
| BTIG | Buy | Buy | Maintain | Mar 27, 2020 |
| SunTrust Robinson Humphrey | Buy | Hold | Upgrade | Mar 17, 2020 |
| First Analysis | Neutral | Outperform | Downgrade | Jan 14, 2020 |
| PiperJaffray | Neutral | Neutral | Maintain | Nov 8, 2019 |
| Bank of America | Underperform | Buy | Downgrade | Sep 19, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jul 26, 2018 |
| BTIG Research | Buy | Neutral | Upgrade | Jul 10, 2018 |
| Argus Research | Hold | Buy | Downgrade | May 9, 2018 |
| Argus | Hold | Buy | Downgrade | May 9, 2018 |
| Cleveland Research | Buy | Buy | Maintain | Apr 24, 2017 |
| Monness Crespi Hardt | Neutral | Neutral | Maintain | Mar 14, 2017 |
| Bernstein | Underperform | Underperform | Maintain | Mar 11, 2016 |
| JMP Securities | Perform | Market Perform | Maintain | Jul 1, 2015 |
| Wunderlich | Buy | Buy | Maintain | Jun 9, 2015 |
| Topeka Capital | Buy | Buy | Maintain | Apr 30, 2014 |
| Topeka | Buy | Buy | Maintain | Apr 30, 2014 |
| Sterne Agee | Buy | Buy | Maintain | Feb 4, 2014 |
| Standpoint Research | Hold | Buy | Downgrade | Jul 10, 2013 |
| Pacific Crest | Sector Perform | Outperform | Downgrade | Apr 23, 2013 |
| Lazard | Neutral | Buy | Downgrade | Mar 25, 2013 |
| Nomura | Buy | Buy | Maintain | Jan 24, 2013 |
| FBN Securities | Outperform | Outperform | Maintain | Oct 17, 2012 |
| Wunderlich Securities | Buy | Hold | Upgrade | Jun 1, 2012 |
| Bank oferica | Neutral | Neutral | Maintain | Mar 19, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $141.5. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Stifel Nicolaus | Adam Borg | $148 | $141.5 | +4.6% | Nov 2, 2026 |
| Jefferies | Analyst unavailable | $185 | $159.84 | +30.7% | Oct 27, 2026 |
| UBS | Roger Boyd | $145 | $138.3 | +2.5% | Oct 15, 2026 |
| Mizuho Securities | Analyst unavailable | $145 | $134.08 | +2.5% | Oct 15, 2026 |
| Wedbush | Analyst unavailable | $135 | $130.51 | -4.6% | Sep 10, 2026 |
| Goldman Sachs | Gabriela Borges | $150 | $127.13 | +6.0% | Aug 1, 2026 |
| Roth Capital | Analyst unavailable | $105 | $125.95 | -25.8% | Jul 31, 2026 |
| UBS | Analyst unavailable | $135 | $127.58 | -4.6% | Jul 31, 2026 |
| Susquehanna | Shyam Patil | $150 | $128.23 | +6.0% | Jul 31, 2026 |
| Stifel Nicolaus | Analyst unavailable | $130 | $128.23 | -8.1% | Jul 31, 2026 |
| Barclays | Analyst unavailable | $140 | $128.23 | -1.1% | Jul 31, 2026 |
| Compass Point | Analyst unavailable | $135 | $130.57 | -4.6% | Jul 27, 2026 |
| UBS | Analyst unavailable | $140 | $130.57 | -1.1% | Jul 27, 2026 |
| Cantor Fitzgerald | Jonathan Ruykhaver | $150 | $125.38 | +6.0% | Jul 23, 2026 |
| Wells Fargo | Richard Poland | $140 | $137.1 | -1.1% | Jul 20, 2026 |
| Barclays | Analyst unavailable | $145 | $131.7 | +2.5% | Jul 13, 2026 |
| Scotiabank | Analyst unavailable | $185 | $136.58 | +30.7% | Jul 6, 2026 |
| Guggenheim | Analyst unavailable | $188 | $131.43 | +32.9% | Jul 1, 2026 |
| BMO Capital | Analyst unavailable | $135 | $114.51 | -4.6% | May 4, 2026 |
| Compass Point | Tal Liani | $120 | $114.51 | -15.2% | May 4, 2026 |
| Goldman Sachs | Analyst unavailable | $168 | $114.51 | +18.7% | May 1, 2026 |
| Morgan Stanley | Analyst unavailable | $133 | $115.79 | -6.0% | May 1, 2026 |
| Scotiabank | Analyst unavailable | $125 | $116.27 | -11.7% | May 1, 2026 |
| UBS | Analyst unavailable | $130 | $116.71 | -8.1% | May 1, 2026 |
| Wedbush | Analyst unavailable | $160 | $115.7 | +13.1% | May 1, 2026 |
| Mizuho Securities | Gregg Moskowitz | $135 | $115.51 | -4.6% | May 1, 2026 |
| Roth Capital | Analyst unavailable | $160 | $115.57 | +13.1% | May 1, 2026 |
| Stifel Nicolaus | Adam Borg | $120 | $112.47 | -15.2% | May 1, 2026 |
| Susquehanna | Analyst unavailable | $140 | $112.47 | -1.1% | May 1, 2026 |
| Jefferies | Joseph Gallo | $160 | $112.47 | +13.1% | May 1, 2026 |
| Barclays | Saket Kalia | $133 | $112.47 | -6.0% | May 1, 2026 |
| Stephens | Todd Weller | $145 | $112.47 | +2.5% | Apr 30, 2026 |
| Cowen & Co. | Analyst unavailable | $180 | $112.47 | +27.2% | Apr 30, 2026 |
| Piper Sandler | Analyst unavailable | $120 | $112.47 | -15.2% | Apr 30, 2026 |
| Truist Financial | Junaid Siddiqui | $150 | $112.52 | +6.0% | Apr 30, 2026 |
| UBS | Analyst unavailable | $175 | $142.05 | +23.7% | Apr 21, 2026 |
| Mizuho Securities | Gregg Moskowitz | $165 | $142.1 | +16.6% | Apr 14, 2026 |
| UBS | Analyst unavailable | $170 | $145.87 | +20.1% | Apr 8, 2026 |
| UBS | Analyst unavailable | $186 | $174.5 | +31.4% | Feb 13, 2026 |
| Scotiabank | Analyst unavailable | $180 | $174.34 | +27.2% | Feb 13, 2026 |
| Robert W. Baird | Shrenik Kothari | $220 | $175.76 | +55.5% | Feb 13, 2026 |
| UBS | Analyst unavailable | $185 | $174.56 | +30.7% | Feb 13, 2026 |
| Evercore ISI | Analyst unavailable | $185 | $172.26 | +30.7% | Feb 13, 2026 |
| Wedbush | Analyst unavailable | $210 | $173.8 | +48.4% | Feb 13, 2026 |
| Deutsche Bank | Brad Zelnick | $180 | $175.33 | +27.2% | Feb 13, 2026 |
| Stephens | Analyst unavailable | $210 | $171.9 | +48.4% | Feb 13, 2026 |
| UBS | Analyst unavailable | $210 | $164.47 | +48.4% | Feb 13, 2026 |
| Mizuho Securities | Gregg Moskowitz | $205 | $164.47 | +44.9% | Feb 13, 2026 |
| UBS | Analyst unavailable | $195 | $164.47 | +37.8% | Feb 13, 2026 |
| UBS | Analyst unavailable | $200 | $164.47 | +41.3% | Feb 12, 2026 |
| Morgan Stanley | Analyst unavailable | $197 | $182.94 | +39.2% | Jan 28, 2026 |
| Scotiabank | Patrick Colville | $195 | $175.38 | +37.8% | Jan 21, 2026 |
| Truist Financial | Analyst unavailable | $225 | $184.81 | +59.0% | Jan 20, 2026 |
| Stephens | Analyst unavailable | $240 | $186.57 | +69.6% | Jan 14, 2026 |
| Piper Sandler | Rob Owens | $240 | $181.03 | +69.6% | Jan 5, 2026 |
| RBC Capital | Matthew Hedberg | $195 | $181.03 | +37.8% | Jan 5, 2026 |
| RBC Capital | Matthew Hedberg | $215 | $197.51 | +51.9% | Oct 29, 2025 |
| Morgan Stanley | Keith Weiss | $212 | $196.66 | +49.8% | Oct 29, 2025 |
| Mizuho Securities | Analyst unavailable | $225 | $203.56 | +59.0% | Oct 29, 2025 |
| BMO Capital | Keith Bachman | $240 | $200.16 | +69.6% | Oct 29, 2025 |
| Scotiabank | Patrick Colville | $210 | $197.14 | +48.4% | Oct 29, 2025 |
| UBS | Roger Boyd | $215 | $203.56 | +51.9% | Oct 29, 2025 |
| Barclays | Saket Kalia | $235 | $203.56 | +66.1% | Oct 29, 2025 |
| Stifel Nicolaus | Analyst unavailable | $211 | $203.56 | +49.1% | Oct 28, 2025 |
| Barclays | Analyst unavailable | $220 | $194.85 | +55.5% | Oct 14, 2025 |
| Scotiabank | Patrick Colville | $205 | $201.57 | +44.9% | Oct 6, 2025 |
| Scotiabank | Analyst unavailable | $220 | $186.67 | +55.5% | Jul 31, 2025 |
| Jefferies | Joseph Gallo | $230 | $186.67 | +62.5% | Jul 31, 2025 |
| Barclays | Analyst unavailable | $215 | $185.51 | +51.9% | Jul 31, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $220 | $186.67 | +55.5% | Jul 30, 2025 |
| Stifel Nicolaus | Analyst unavailable | $200 | $186.67 | +41.3% | Jul 30, 2025 |
| BMO Capital | Keith Bachman | $250 | $204.26 | +76.7% | Apr 23, 2025 |
| Roth Capital | Taz Koujalgi | $215 | $212.31 | +51.9% | Apr 22, 2025 |
| Stephens | Todd Weller | $255 | $227.92 | +80.2% | Mar 31, 2025 |
| Compass Point | Analyst unavailable | $260 | $231.31 | +83.7% | Mar 27, 2025 |
| Morgan Stanley | Analyst unavailable | $235 | $229.75 | +66.1% | Mar 18, 2025 |
| Piper Sandler | Analyst unavailable | $260 | $221.09 | +83.7% | Mar 3, 2025 |
| Susquehanna | Shyam Patil | $255 | $218.02 | +80.2% | Jan 31, 2025 |
| Robert W. Baird | Shrenik Kothari | $235 | $218.02 | +66.1% | Jan 31, 2025 |
| Jefferies | Joseph Gallo | $225 | $186.85 | +59.0% | Dec 19, 2024 |
| Deutsche Bank | Brad Zelnick | $200 | $182.82 | +41.3% | Dec 2, 2024 |
| Compass Point | Tal Liani | $195 | $173.89 | +37.8% | Oct 30, 2024 |
| Robert W. Baird | Shrenik Kothari | $205 | $177.87 | +44.9% | Oct 30, 2024 |
| Barclays | Saket Kalia | $200 | $177.87 | +41.3% | Oct 29, 2024 |
| Robert W. Baird | Shrenik Kothari | $210 | $205.28 | +48.4% | Oct 22, 2024 |
| Goldman Sachs | Gabriela Borges | $208 | $181.17 | +47.0% | Jul 25, 2024 |
| Scotiabank | Patrick Colville | $200 | $181.95 | +41.3% | Jul 25, 2024 |
| RBC Capital | Matthew Hedberg | $187 | $181.95 | +32.2% | Jul 25, 2024 |
| BMO Capital | Keith Bachman | $200 | $180.07 | +41.3% | Jul 25, 2024 |
| Evercore ISI | Peter Levine | $180 | $180.07 | +27.2% | Jul 25, 2024 |
| Barclays | Saket Kalia | $175 | $152.95 | +23.7% | Apr 26, 2024 |
| Susquehanna | Shyam Patil | $200 | $164.77 | +41.3% | Feb 7, 2024 |
| Piper Sandler | Rob Owens | $128 | $129.45 | -9.5% | Oct 30, 2023 |
| Morgan Stanley | Hamza Fodderwala | $144 | $136.14 | +1.8% | Oct 16, 2023 |
| Credit Suisse | Sami Badri | $105 | $120.75 | -25.8% | May 2, 2023 |
| Jefferies | Analyst unavailable | $150 | $126.58 | +6.0% | Jan 5, 2023 |
| SMBC Nikko | Carson Sippel | $115 | $113.75 | -18.7% | Oct 6, 2022 |
| Credit Suisse | Phil Winslow | $115 | $118.39 | -18.7% | Aug 2, 2022 |
| Citigroup | Analyst unavailable | $120 | $128.86 | -15.2% | Jul 22, 2022 |
| Wells Fargo | Analyst unavailable | $130 | $127.65 | -8.1% | Apr 28, 2022 |
| Wells Fargo | Analyst unavailable | $144 | $135.82 | +1.8% | Apr 25, 2022 |
| RBC Capital | Analyst unavailable | $145 | $137.27 | +2.5% | Apr 25, 2022 |
| Evercore ISI | Irvin Liu | $140 | $128.26 | -1.1% | Feb 4, 2022 |
| Mizuho Securities | Gregg Moskowitz | $125 | $126.68 | -11.7% | Feb 3, 2022 |
| Robert W. Baird | Jonathan Ruykhaver | $140 | $126.68 | -1.1% | Feb 3, 2022 |
| Morgan Stanley | Keith Weiss | $120 | $126.68 | -15.2% | Feb 3, 2022 |
| J.P. Morgan | Sterling Auty | $142 | $126.68 | +0.4% | Feb 3, 2022 |
| Jefferies | Brent Thill | $130 | $121.07 | -8.1% | Feb 1, 2022 |
| Wells Fargo | Andrew Nowinski | $115 | $119.31 | -18.7% | Jan 28, 2022 |
| Citigroup | Fatima Boolani | $115 | $124.24 | -18.7% | Jan 24, 2022 |
| Raymond James | Adam Tindle | $140 | $126.14 | -1.1% | Jan 14, 2022 |
| UBS | Roger Boyd | $125 | $114.24 | -11.7% | Dec 17, 2021 |
| Bank of America Securities | Tal Liani | $130 | $119.6 | -8.1% | Oct 29, 2021 |
| Goldman Sachs | Brian Essex | $121 | $118.73 | -14.5% | Oct 28, 2021 |
| BTIG | Gray Powell | $153 | $118.73 | +8.1% | Oct 28, 2021 |
Track every rating change on CHKP the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCheck Point Software Technologies Ltd. is a global provider specializing in the development, marketing, and support of comprehensive information technology security solutions. Their extensive portfolio addresses critical areas such as network, endpoint, and data security, alongside various management tools. A cornerstone of their offerings is the Check Point Infinity Architecture, a unified cybersecurity framework engineered to combat advanced 5th and 6th generation cyber threats. This architecture provides robust protection across a diverse range of environments, including traditional networks, individual endpoints, cloud infrastructures, workloads, Internet of Things (IoT) devices, and mobile platforms. The company also supplies powerful security gateways and sophisticated software platforms, scalable to meet the needs of organizations from small and medium-sized businesses (SMBs) up to large enterprise data centers and telecommunications-grade environments.…
Historical context
All CHKP earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| TSEM Tower Semiconductor Ltd. | FY2026 Q3 · Calendar Q4 2026 | — | -6.7% | Tower Semiconductor Q3: record results, capacity expansion |
| INTC Intel Corp. | FY2026 Q3 · Calendar Q4 2026 | +27.9% | -28.6% | Intel: AI Server Demand Offsets PC Weakness, CapEx Rises |
| GDDY GoDaddy Inc. | FY2026 Q3 · Calendar Q4 2026 | +9.5% | +10.7% | GoDaddy: Airo accelerates while guidance is maintained |
Latest beats and misses
Who reports nextBeat on EPS
- MARFY2026 Q3 · November 2, 2026+6.3% EPS+4.3% move
- NBIXFY2026 Q3 · November 2, 2026+72.3% EPS-0.5% move
- AXSMFY2026 Q3 · November 2, 2026+60.6% EPS-5.8% move
- TEMFY2026 Q3 · November 2, 2026+174.7% EPS+8.7% move
- BWXTFY2026 Q3 · November 2, 2026+6.8% EPS-0.2% move
- CUBEFY2026 Q3 · October 29, 2026+2.3% EPS+4.0% move
Missed on EPS
- RYAAYFY2027 Q2 · November 2, 2026-0.3% EPS+2.9% move
- GLPIFY2026 Q3 · October 29, 2026-11.5% EPS-1.3% move
- LYBFY2026 Q3 · October 30, 2026-1.2% EPS+5.0% move
- CCJFY2026 Q3 · October 30, 2026-101.4% EPS-7.9% move
- VALEFY2026 Q3 · October 29, 2026-24.6% EPS+1.9% move
- PINSFY2026 Q3 · October 29, 2026-5.4% EPS-2.8% move
Get the CHKP recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-11-03T01:00:48.511474+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-03T01:00:48.508699+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-03. For educational purposes only; not investment advice.